|1.||Swartz, Karin R: 1 article (06/2010)|
|2.||Fee, Dominic B: 1 article (06/2010)|
|3.||Gabbita, Prasad: 1 article (06/2010)|
|4.||Roberts, Kelly: 1 article (06/2010)|
|5.||Scheff, Stephen: 1 article (06/2010)|
|6.||Scheff, Nicole: 1 article (06/2010)|
|7.||Mulchahey, J Jeffery: 1 article (03/2005)|
|8.||Mayleben, David W: 1 article (03/2005)|
|9.||Rosenberg, Russell: 1 article (03/2005)|
|10.||Scharf, Martin B: 1 article (03/2005)|
|1.||Sleep Initiation and Maintenance Disorders (Insomnia)
03/01/2005 - "A double-blind, placebo-controlled, crossover safety and efficacy study of 20 mg, 50 mg, and 100 mg of beta-methyl-6-chloromelatonin and placebo was conducted in subjects with DSM-IV-TR primary insomnia. "
03/01/2005 - "beta-Methyl-6-chloromelatonin significantly decreases both objective and subjective measures of sleep latency in subjects with primary insomnia. "
03/01/2005 - "The purpose of the present study was to determine if the melatonin agonist beta-methyl-6-chloromelatonin has a direct soporific effect in subjects with primary insomnia. "
03/01/2005 - "The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial."
03/01/2005 - "beta-Methyl-6-chloromelatonin is a high-affinity melatonin receptor agonist that is not associated with hypothermia. "
08/27/2004 - "beta-methyl-6-chloromelatonin appears safe and well tolerated at doses up to 100 mg. These doses are not associated with hypothermia, bradycardia or hypotension. "
|3.||Spinal Cord Injuries (Spinal Cord Injury)
|4.||Hypotension (Low Blood Pressure)
|2.||Melatonin Receptors (Melatonin Receptor)